WarfarinAnticoagulantsInternational Normalized RatioVitamin K Epoxide ReductasesThromboembolismAtrial FibrillationHemorrhageProthrombin TimeAtrial Appendagebeta-AlaninePharmacogeneticsAryl Hydrocarbon HydroxylasesDrug MonitoringMixed Function OxygenasesVitamin KStrokeOral Surgical ProceduresVenous ThrombosisPulmonary EmbolismAspirinThrombosisDrug InteractionsBlood CoagulationEmbolismTreatment OutcomeFactor VIIVenous ThromboembolismRetrospective StudiesRisk FactorsEchocardiography, TransesophagealDose-Response Relationship, DrugBlood Loss, SurgicalProspective StudiesAdministration, OralFollow-Up StudiesGenotypeDrug Administration ScheduleRecurrenceCohort StudiesRisk AssessmentRodenticidesTime FactorsPractice Guidelines as TopicAlgorithmsPostoperative ComplicationsVitamin K 1